At a glance
ClinicalIndex Comparison RecordN/ACompleted· 9 enrolled
Drug / intervention
Valiant Mona LSA Stent Graft Systemdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Valiant Mona LSA Stent Graft System Early Feasibility Study
In Brief
A clinical study evaluating Valiant Mona LSA Stent Graft System for Thoracic Aortic Aneurysms. Completed, enrolled 9 participants across 3 sites in 2 countries.
Detailed Summary
The Valiant Mona LSA thoracic stent graft system is for the endovascular repair of aneurysms of the descending thoracic aorta (DTA) in patients who require coverage of the left subclavian artery (LSA).The study is intended to assess safety and performance of the device acutely and at 30 days.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsThoracic Aortic Aneurysms
CountriesUnited Kingdom, United States
Collaborators--
Timeline
N/ACompletedFinished
20132014201520162017201820192020202120222023202420252026
Enrollment StartApr 2013
First PostedApr 2013
Primary CompletionFeb 2014
Study CompletionDec 2018
TodayJul 2026
First PostedApr 25, 2013
Enrollment StartApr 1, 2013
Primary CompletionFeb 1, 2014
Study CompletionDec 1, 2018
TodayJul 2, 2026
Enrollment to primary: 10 monthsPosted 13.2 years ago
Interventions
Valiant Mona LSA Stent Graft Systemdevice
All subjects will be implanted with this device